Medicamen Biotech Ltd. | Cash Flow
Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
941.80
4,406.30
4,808.90
51,601.00
-
Depreciation, Depletion & Amortization
16,093.50
20,967.20
18,968.80
19,223.30
-
Other Funds
423.60
-
-
-
-
Funds from Operations
18,500.80
22,193.80
26,346.40
82,810.50
121,706.00
Changes in Working Capital
5,293.80
80,945.60
6,078.30
76,475.50
-
Net Operating Cash Flow
23,794.50
58,751.80
32,424.70
6,335.10
-
Capital Expenditures
9,798.00
946.40
6,737.20
23,197.80
-
Purchase/Sale of Investments
-
-
-
500.00
-
Net Investing Cash Flow
9,798.00
946.40
6,737.20
23,697.80
-
Issuance/Reduction of Debt, Net
15,072.10
48,686.50
18,748.00
17,227.30
-
Net Financing Cash Flow
7,807.40
55,528.00
16,314.60
19,892.30
-
Net Change in Cash
6,189.10
4,170.20
9,372.80
2,529.60
-
Free Cash Flow
13,996.50
59,698.20
25,687.50
16,862.70
-
Deferred Taxes & Investment Tax Credit
504.80
3,427.40
873.40
978.50
-
Change in Capital Stock
6,841.10
6,841.50
2,433.40
37,119.50
-
About Medicamen Biotech
View Profile
